Aztreonam IV 2 g every 8 hours plus metronidazole IV 500 mg every 12 hours
Add vancomycin for MRSA
Carbapenem use only if allergy history supports safety with specialist input
Osteomyelitis pathways
Osteomyelitis management framework
Diagnostic anchors
Positive probe-to-bone in high-pretest setting
MRI supportive findings
Bone biopsy culture when feasible
Treatment duration concepts
After complete surgical resection with clean margins, shorter course possible
Without resection, prolonged antibiotics typical 6 weeks
Surgical indications
Necrotic bone
Persistent sinus tract
Failure of medical therapy
Antibiotic route considerations
IV to oral switch when clinically improving and oral bioavailability high
Adjunctive medical management
Supportive care and comorbidity optimization
Fluid resuscitation for sepsis physiology (Class I)
Balanced crystalloid bolus guided by perfusion
Reassess MAP, urine output, lactate trend
Analgesia strategy
Acetaminophen dosing within daily limits
Opioid sparing plan when possible
Glycemic management
Insulin protocol alignment for inpatient care
Avoid sliding scale alone in severe infection
VTE prophylaxis for admitted patients
Pharmacologic prophylaxis unless contraindicated
Smoking cessation support
PAD and wound healing benefit framing
Special Populations
Pregnancy
Pregnancy considerations
Antibiotic safety
Avoid doxycycline
Avoid trimethoprim-sulfamethoxazole in first trimester and near term when possible
Beta-lactams generally preferred when appropriate
Imaging considerations
MRI without gadolinium preferred when needed
CT only if benefits outweigh risks
Multidisciplinary coordination
Obstetrics input for severe infection or inpatient management
Geriatric
Older adult considerations
Atypical infection presentation
Minimal fever despite severe infection
Delirium as first sign
Medication safety
Renal dosing vigilance
Drug interaction review for linezolid and SSRIs
Disposition risks
Falls risk with offloading devices
Home support assessment
Pediatrics
Pediatric considerations
Lower prevalence of true diabetic foot ulcers
Alternate etiologies consideration
Weight-based antibiotic dosing
Pharmacy consult for dosing
Child protection context when indicated
Neglect concerns if chronic wound with delayed care
Background
Epidemiology
Epidemiology overview
Diabetic foot ulcers as common diabetes complication
Increased lifetime risk among patients with diabetes
Infection as frequent driver of hospitalization and amputation
PAD and neuropathy as major risk amplifiers
Recurrence risk
High recurrence without sustained offloading and footwear modifications
Pathophysiology
Mechanisms driving infection and poor healing
Neuropathy
Loss of protective sensation leading to repetitive trauma
Motor imbalance causing pressure points
Peripheral arterial disease
Reduced oxygen delivery and impaired immune response
Hyperglycemia
Impaired neutrophil function
Collagen synthesis impairment
Polymicrobial biofilm formation
Chronicity and antibiotic tolerance
Therapeutic Considerations
Treatment principles rationale
Source control centrality
Debridement reduces bacterial burden and necrotic substrate
Antibiotic spectrum selection by severity
Overly broad therapy in mild cases increases harm
Under-treatment in severe cases increases limb loss risk
Perfusion restoration impact
Revascularization improves healing in ischemic ulcers
Multidisciplinary care benefits
Podiatry, vascular, infectious diseases, wound care coordination
Patient Discharge Instructions
copy discharge instructions
Home care and follow-up plan
Offloading
Keep weight off affected area as instructed
Use boot or shoe device at all times when walking
Wound care
Keep dressing clean and dry
Change dressings as instructed
Avoid soaking the foot unless specifically instructed
Medications
Take antibiotics exactly as prescribed
Do not stop early even if improved
Diabetes management
Check glucose regularly
Follow sick-day plan if provided
Follow-up timing
Wound clinic or primary care within 48 to 72 hours for infected ulcers
Earlier follow-up if worsening
Return to ED immediately for red flags
Fever or chills
Rapidly increasing redness or swelling
New foul odor or rapidly increasing drainage
Black or blue skin discoloration
Severe or rapidly worsening pain
New numbness or cold foot
Dizziness, confusion, fainting, or trouble breathing
Persistent vomiting or inability to keep fluids down
References
Clinical guidelines and evidence sources
Evidence and guideline anchors
IDSA guideline for diabetic foot infections
Severity classification framework
Culture technique recommendations
Antibiotic selection principles
IWGDF guidance on diabetic foot infection and osteomyelitis
Imaging pathways
WIfI and limb threat concepts
Surviving Sepsis Campaign recommendations
Early antibiotics in sepsis and septic shock (Class I)
Early fluid resuscitation targets (Class I)
ACEP sepsis clinical policy alignment
Lactate for risk stratification (ACEP Level B)
Early broad-spectrum antibiotics in septic shock (ACEP Level B)
Vancomycin monitoring consensus
AUC-guided monitoring preferred over trough-only strategies
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.